Health Condition 1: T07- Unspecified multiple injuries
Conditions
Interventions
Intervention1: Regular Insulin also called Soluble Insulin: 4 units (0.1 ml) of human soluble insulin in 1 ml normal saline (0.9%) for each 10 cm2 of wound, every 48 hours for 14 days
Control Interven
Sponsors
Dr Meenu Thomas
Eligibility
Inclusion criteria
Inclusion criteria: Age18-65 years old Either gender Class I and II wound classifications as per CDC Wound surface area (less than 20cm2) Patients willing to give informed consent
Exclusion criteria
Exclusion criteria: Pregnancy Patients on immunosuppressive treatment Wounds that are complicated (e.g., Bleeding or infection) Medications that may impact the study’s outcome Cardiovascular illnesses, Peripheral artery disease or Renal and hepatic failure
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To study the effectiveness of topical insulin on wound healingTimepoint: Wound area in mm square shall be measured at day zero then at day 7 and then 14. | — |
Secondary
| Measure | Time frame |
|---|---|
| To study effectiveness & safety of topical insulin on wound healingTimepoint: For effectiveness Wound depth in mm measured at day 7 & 14 The average time in which granulation tissue appears measured. For safety Random blood glucose 10 minutes before & after insulin application measured. Spontaneously reported Adverse Drug Reactions (ADRs) noted as per ADR checklist at day zero then at day 7 & 14. | — |
Countries
India
Contacts
Public ContactDr Meenu Thomas
Teerthanker Mahaveer University Medical College and Research Centre
Outcome results
None listed